Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Saw · SciRah

Researcher profile · Semantic Scholar

S. Saw

Share profile

S. Saw — researcher profile on SciRah

h-index: 11
Works: 45
Citations: 661

Most-cited papers

Revisiting neoadjuvant therapy in non-small-cell lung cancer.
S. Saw, B. Ong, K. Chua, A. Takano +1 more
2021The Lancet Oncology164 citations
Semantic Scholar
MET alterations in NSCLC-Current Perspectives and Future Challenges.
J. Remon, L. Hendriks, G. Mountzios, R. García-Campelo +5 more
2022Journal of Thoracic Oncology135 citations Open access
Semantic Scholar
Pembrolizumab-induced Stevens-Johnson syndrome in non-melanoma patients.
S. Saw, H. Lee, Q. Ng
2017European Journal of Cancer102 citations
Semantic Scholar
Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management
Maxime Borgeaud, Timothée Olivier, J. Bar, S. Saw +6 more
2025Ca49 citations Open access
Semantic Scholar
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung cancer
A. Tan, G. Lai, S. Saw, K. Chua +20 more
2024Cancer48 citations Open access
Semantic Scholar
Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer
S. Saw, Siqin Zhou, Jianbin Chen, G. Lai +20 more
2021JAMA Network Open43 citations Open access
Semantic Scholar
PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancer.
S. Saw, W. Ng, Siqin Zhou, G. Lai +18 more
2022European Journal of Cancer23 citations Open access
Semantic Scholar
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC
G. Lai, Jia-Chi Yeo, Amit L. Jain, Siqin Zhou +29 more
2022JTO Clinical and Research Reports15 citations Open access
Semantic Scholar
Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice
S. Saw, J. Lim, S. Lim, M. Wong +2 more
2019Breast Cancer Research and Treatment14 citations
Semantic Scholar
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer.
S. Saw, Wen-Zhao Zhong, Rui Fu, Molly S. C. Li +17 more
2025Lung Cancer11 citations Open access
Semantic Scholar
Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer.
A. Tan, S. Saw, Jianbin Chen, G. Lai +17 more
2022JCO Precision Oncology11 citations
Semantic Scholar
PRACTICAL BARRIERS TO IMPLEMENTATION OF THYROID CANCER GUIDELINES IN THE ASIA-PACIFIC REGION.
S. P. Yang, L. Ying, S. Saw, R. M. Tuttle +2 more
2015Endocrine Practice11 citations
Semantic Scholar
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC.
S. Saw, Yi Fen Low, G. Lai, Landon L. Chan +16 more
2024Lung Cancer7 citations Open access
Semantic Scholar
Oncogene-driven non-small cell lung cancers in patients with a history of smoking lack smoking-induced mutations.
Chen-Yang Huang, Nanhai Jiang, Meixin Shen, G. Lai +19 more
2024Cancer Research7 citations Open access
Semantic Scholar
Abstract 5114: Ultra-sensitive detection of minimal residual disease (MRD) through whole genome sequencing (WGS) using an AI-based error suppression model in resected early-stage non-small cell lung cancer (NSCLC)
A. Tan, S. Saw, G. Lai, K. Chua +27 more
2022Cancer Research6 citations
Semantic Scholar
Co-targeting the VEGF axis and immune checkpoints in NSCLC: back to the future.
S. Saw, D. Tan
2021Annals of Oncology4 citations Open access
Semantic Scholar
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancer.
S. Saw, Angela M. Takano, Siqin Zhou, N. O. Hlaing +16 more
2025Lung Cancer3 citations Open access
Semantic Scholar
Immunotherapy with chemotherapy and anti-angiogenic therapy for EGFR mutated NSCLC: challenging the dogma
A. Tan, Keigo Kobayashi, S. Saw, D. S. Tan +1 more
2022Expert Review of Anticancer Therapy3 citations Open access
Semantic Scholar
Multidisciplinary lung cancer clinic: An emerging model of care.
S. Saw, K. Chua, B. Ong, D. Lim +3 more
2022Annals of the Academy of Medicine, Singapore3 citations Open access
Semantic Scholar
Elucidating the genomic and transcriptomic landscape of L858R vs ex19del EGFR-mutated NSCLC.
S. Saw, Meng-Yuan Pang, Jia-Chi Yeo, J. Alvarez +15 more
2023Journal of Clinical Oncology1 citations
Semantic Scholar
Diverse Resistant Mechanisms Identified Using Serial Next-Generation Sequencing in a Patient With ALK-Rearranged Metastatic Lung Adenocarcinoma: A Case Report
S. Saw, D. W. Lim
2023JTO Clinical and Research Reports1 citations Open access
Semantic Scholar
Circulating tumour DNA (ctDNA) burden quantified through low-pass whole genome sequencing as an early pharmacodynamic biomarker of therapeutic response in patients enrolled on phase 1 trials.
A. Tan, Y. Guo, C. Rahman, T. Tan +16 more
2023JCO Global Oncology1 citations Open access
Semantic Scholar
Trials without borders—decentralized trials and ensuring access to novel cancer therapies during a global pandemic
Aaron C. Tan, Tira J. Tan, S. Saw, J. Lam +5 more
2022ESMO Open1 citations Open access
Semantic Scholar
OA06.05 Molecular and Clinical Features Associated with Relapse in Early Stage EGFR-Mutated NSCLC: A Single Institution Knowledge Bank
S. Saw, G. Lai, S. Zhou, J. Chen +17 more
20211 citations Open access
Semantic Scholar
Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026.
M. Bortolot, S. Saw, Erica Pietroluongo, G. Rajath +3 more
2026American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting0 citations
Semantic Scholar
MO13.05: Real-World Uptake and Outcomes of Adjuvant Osimertinib in EGFR-mutated NSCLC and Impact of TP53 Co-Mutations
C. Patteri, A. Seet, D. Ang, A. Tan +14 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
Abstract LT05: How EGFR Mutations Shape Lung Cancer in Never-Smokers
Komal Gupta, Dawn Lau Pingxi, Kenneth Chow, N. Sim +6 more
2026Cancer Research0 citations
Semantic Scholar
Integrated multi-omic profiling enables recurrence risk stratification beyond pathological stage in resected EGFR-mutant lung adenocarcinoma.
S. Saw, Meng-Yuan Pang, Jia-Chi Yeo, J. Alvarez +22 more
2026Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
PP01.23: A Novel Lung Cancer Patient Navigation (LCPN) Programme in a Tertiary Oncology Centre in Singapore— through the Consolidated Framework for Implementation Research (CFIR) lens
Caluag Aira Mheleen Avendano, R. Teng, M. Ang, G. Lai +4 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
Early EGFR Inhibition Triggers Actionable Tumor and Microenvironmental Remodeling in Lung Cancer
Aaron C. Tan, Jia-Chi Yeo, J. Alvarez, Meng-Yuan Pang +24 more
2026Cancer Research Communications0 citations Open access
Semantic Scholar
Genomic and transcriptomic landscape of spread through air spaces in stage 1 lung adenocarcinoma.
S. Saw, Meng-Yuan Pang, C. Patteri, Angela M. Takano +16 more
2026British Journal of Cancer0 citations Open access
Semantic Scholar
Abstract 1251: Decoding tumour evolution and relapse drivers in EGFR mutant NSCLC in never smokers
Komal Gupta, Dawn Lau Pingxi, N. Sim, Kenneth Chow +7 more
2025Cancer Research0 citations
Semantic Scholar
Advancing the Needle on the Management of Resectable EGFR-Positive NSCLC: Is Neoadjuvant Osimertinib the Answer?
C. Park, S. Saw
2025Journal of Thoracic Oncology0 citations
Semantic Scholar
Genomic characterization of STAS in stage 1 EGFR-mutated NSCLC and prognostic implications.
S. Saw, Meng-Yuan Pang, C. Patteri, Angela M. Takano +16 more
2025Journal of Clinical Oncology0 citations
Semantic Scholar
Distant Cousins From the Same Family-Understanding Uncommon EGFR Mutations.
S. Saw, Molly S. C. Li
2025Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
Abstract 1748: Dearth of smoking-induced mutations in oncogene-driven NSCLCs despite smoking exposure
Chen-Yang Huang, Nanhai Jiang, Meixin Shen, G. Lai +19 more
2024Cancer Research0 citations
Semantic Scholar
Title: Dearth of smoking-induced mutations in NSRO-driven non-small-cell lung cancer despite smoking exposure Running title: Dearth of smoking mutations in NSRO-driven NSCLC Authors:
Chen-Yang Huang, Nanhai Jiang, Meixin Shen, G. Lai +21 more
20230 citations
Semantic Scholar
Dearth of smoking-induced mutations in NSRO-driven non-small-cell lung cancer despite smoking exposure
Chen-Yang Huang, Nanhai Jiang, Meixin Shen, G. Lai +19 more
2023bioRxiv0 citations Open access
Semantic Scholar
Real world outcomes of patients with non-clear cell renal cell carcinoma: A single Asian centre experience.
J. Chan, Daniel Peh, W. Tan, Hui-Shan Tan +8 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate Measure
S. Saw, Gek-San Tan, W. Tan, A. Tan +8 more
2023JTO Clinical and Research Reports0 citations Open access
Semantic Scholar
Identifying correlates of post treatment responses for unresectable locally advanced non-small cell lung cancer (LA NSCLC).
K. Chua, G. Lai, A. Tan, S. Saw +16 more
2023JCO Global Oncology0 citations Open access
Semantic Scholar
Heterogeneity of PD-L1 expression among resected EGFR-mutated NSCLC and prognostic implications.
S. Saw, N. O. Hlaing, Siqin Zhou, Anne James +15 more
2023JCO Global Oncology0 citations Open access
Semantic Scholar
PD-L1 score as a prognostic biomarker in Asian patients with early-stage, EGFR-mutated lung cancer.
S. Saw, G. Lai, A. Tan, Siqin Zhou +12 more
2022Journal of Clinical Oncology0 citations
Semantic Scholar
PD-L1 Score as a Prognostic Biomarker in Asian Early-Stage EGFR-Mutated Lung Cancer
S. Saw, W. Ng, Siqin Zhou, G. Lai +18 more
2022Social Science Research Network0 citations Open access
Semantic Scholar
EP16.03-036 Clinical and Genomic Features of HER2 exon 20 Insertion Mutations in East Asian NSCLC
S. Saw, A. Tan, J. Chen, G. Lai +17 more
2022Journal of Thoracic Oncology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Kanesvaran×26
Invite
R. Kanesvaran — researcher profile on SciRah
Q. Ng×25
Invite
Q. Ng — researcher profile on SciRah
W. Tan×25
Invite
W. Tan — researcher profile on SciRah
G. Lai×22
Invite
G. Lai — researcher profile on SciRah

×20

Invite

A. Skanderup — researcher profile on SciRah

Invite

B. Ong — researcher profile on SciRah

Invite

A. Tan — researcher profile on SciRah

Invite

A. Takano — researcher profile on SciRah

Invite

M. Ang — researcher profile on SciRah

Invite

D. W. Lim — researcher profile on SciRah

Invite

D. S. Tan — researcher profile on SciRah

Amit L. Jain×13

Invite

Amit L. Jain — researcher profile on SciRah